Recent advances in mantle cell lymphoma: Expert panel discussion
Recent advances in mantle cell lymphoma: Expert panel discussion
Lecture: Clinical perspectives: Non-AR therapeutic targets in CRPC
Rituximab versus idelalisib in refractory CLL
Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic lymphocytic leukaemia patients
WIN Symposium 2014: Breakthrough biomarker investigations and combination therapies
Work and history of the Kidney Cancer Association
Intratumour heterogeneity in renal and lung cancer
Kidney cancer treatment ten years from now
Personalisation of leukaemia treatment using genome sequencing
High levels of mutated p53 indicate metastatic phenotype
History and ongoing work of AORTIC
AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya